Market Samachar
Home  ›  GLOBAL
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
GURUFOCUS.COM · GLOBAL ·

Hutchmed (HCM) Launches Phase Ia Trial for HMPL-A830 in Advanced Solid Tumors

As reported by gurufocus.com
On September 27, 2026, Hutchmed (NASDAQ: HCM) announced the initiation of the Phase Ia segment of a global clinical trial investigating HMPL-A830, a novel thera...
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar